GTCR is running a continuation vehicle process for a wireless carrier it acquired five years ago, Secondaries Investor has learned. The Chicago-based private equity firm has launched a single-asset CV ...
LET’S GET TECHNICAL. Scientists from the biotech company Life Biosciences are investigating the safety and potential side ...
Morning Overview on MSN
The first cellular age-reversal therapy has been cleared for human trials
Life Biosciences has received FDA clearance to begin a first-in-human Phase 1 clinical trial of ER-100, a gene therapy ...
Today, more people are living past 100 than ever before — even though the maximum human lifespan hasn't moved past 115 years.
Blindness itself might become, at least in certain cases, partially reversible. This potential future stems from one of the ...
Plant regeneration represents a cornerstone of modern plant science, blending fundamental questions in developmental biology ...
Signal transduction and gene regulation are at the heart of cell and developmental biology, driving cell fate decisions and tissue homeostasis. In cancer, ...
With fresh focus on New Approach Methodologies (NAMs) to move away from animal models in biosciences and preclinical ...
Russia’s Burevestnik cruise missile—codenamed "Skyfall" by NATO—represents a dramatic leap in nuclear weapons technology.
A new book by New York Times reporters Maggie Haberman and Jonathan Swan claims JD Vance suggested India and Saudi Arabia as ...
Sparkling Sciences Co., Ltd., under TOMO YUME Group, announced it has obtained international INCI certification for iPSC Exosome and completed Kyoto University's patent licensing agreement. INCI Name: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results